BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Togashi J, Sugawara Y, Akamatsu N, Tamura S, Tanaka T, Kaneko J, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N. A Single-Center Experience of the Use of Interleukin-2 Receptor Antagonists for Various Situations in Liver Transplant Recipients. Transplantation Proceedings 2014;46:739-43. [DOI: 10.1016/j.transproceed.2013.11.075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Hashim M, Alsebaey A, Ragab A, Soliman HE, Waked I. Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study. Annals of Hepatology 2020;19:541-5. [DOI: 10.5604/01.3001.0012.2246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yang X, Lu D, Wang R, Lian Z, Lin Z, Zhuo J, Chen H, Yang M, Tan W, Yang M, Wei X, Wei Q, Zheng S, Xu X. Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation. Cell Prolif 2021;54:e13116. [PMID: 34469018 DOI: 10.1111/cpr.13116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Assadiasl S, Mooney N, Nicknam MH. Cytokines in Liver Transplantation. Cytokine 2021;148:155705. [PMID: 34564024 DOI: 10.1016/j.cyto.2021.155705] [Reference Citation Analysis]
4 Verbiest A, Pirenne J, Dierickx D. De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Reviews 2014;28:269-79. [DOI: 10.1016/j.blre.2014.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]